Clinical trial
A Prospective Observational Study of the Efficacy and Safety of CPT-11 Based Regimens for UGT1A1 Genotype Guided Patients With Metastatic Colorectal Cancer
NCT01039506 is registered in ClinicalTrials.gov with Daiichi Sankyo Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study of the Efficacy and Safety of CPT-11 Based Regimens for UGT1A1 Genotype Guided Patients With Metastatic Colorectal Cancer
- Lead sponsor
- Daiichi Sankyo Co., Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 15, 2009
- Completion date
- July 1, 2016
- Enrollment
- 1,376 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic colorectal cancer